Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SMD Rise PCL's revenue per share for the
three
months ended in Mar. 2026 was ฿0.85.
SMD Rise PCL's revenue per share for the trailing twelve months (TTM) ended in Mar. 2026 was ฿4.50.
Warning Sign:
SMD Rise PCL revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue Per Share Growth Rate of SMD Rise PCL was 15.50% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was -21.20% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was -7.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for SMD Rise PCL's Revenue per Share or its related term are showing as below:
BKK:SMD100-R'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -22.5 Med: -11.65 Max: 48.1
Current: -21.2
During the past 8 years, SMD Rise PCL's highest 3-Year average Revenue Per Share Growth Rate was 48.10% per year. The lowest was -22.50% per year. And the median was -11.65% per year.
BKK:SMD100-R's 3-Year Revenue Growth Rate is ranked worse than 91.15% of 113
companies
in the Medical Distribution industry
Industry Median: 4.7
vs BKK:SMD100-R: -21.20
SMD Rise PCL (BKK:SMD100-R) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
SMD Rise PCL Revenue per Share Related Terms
SMD Rise PCL Revenue per Share Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100-R vs MCK, CAH, COR: Revenue per Share Comparison
For the Medical Distribution subindustry, SMD Rise PCL's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's PS Ratio distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
SMD Rise PCL's Revenue Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿4.50
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMD Rise PCL (BKK:SMD100-R) has a Revenue per Share of ฿4.50 as of Mar. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on SMD Rise PCL and its competitors. According to the industry distribution chart, SMD Rise PCL ranks #103 out of 113 companies in the Medical Distribution industry, placing it in the top 91.2%.
Is SMD Rise PCL's Revenue per Share too high?
SMD Rise PCL's current Revenue per Share is ฿4.50. Based on the distribution chart, SMD Rise PCL ranks #103 out of 113 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's Revenue per Share compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #103 out of 113 companies for Revenue per Share. This places SMD Rise PCL in the lower half of its industry. The industry median Revenue per Share is 4.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Medical Distribution company?
The median Revenue per Share among Medical Distribution companies is 4.70, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median Revenue per Share is 4.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current Revenue per Share is ฿4.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current Revenue per Share of ฿4.50. The stock's GF Value™ is ฿22.11, compared to a current price of ฿5.85 — trading 73.5% below its estimated fair value. The current Revenue per Share is ฿4.50. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current Revenue per Share is ฿4.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 73.5% below its estimated GF Value™ of ฿22.11.
Key valuation signals for BKK:SMD100-R:
Revenue per Share: ฿4.50
GF Value™: ฿22.11 vs. price of ฿5.85 (73.5% below fair value)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
